Its effective concentration ranges from the sub-nanomolar to nanomolar range, with 500 nM commonly used in vitro to ensure full TrkB activation
This concentration of research in one group is relevant context for interpreting the literature
AOD-9604 Research Protocols & Administration Dosing in Published Research Research investigations have employed diverse AOD-9604 doses across species and administration routes: Rodent studies: 250-500 mcg/kg orally or intraperitoneally was most common for obesity research Rabbit models: 0.25 mg per joint for osteoarthritis studies (intra-articular injection) Pig pharmacokinetic studies: 1.5 mg/kg IV and 2 mg/kg oral for metabolism characterization Human clinical trials: Oral doses of 0.25-10 mg daily
[DOI] [PMC free article] [PubMed] [Google Scholar] 72.Morris D., Khurasany M., Nguyen T., Kim J., Guilford F., Mehta R., Gray D., Saviola B., Venketaraman V
Chitosan/silk fibroin materials for biomedical applicationsa review
Athletes often use it for recovery and reducing physical stress from intense workouts